• Gout linked to 14% higher risk for Parkinson's disease in elders

    Study of 1.72 million Medicare recipients shows highest risk at age 65-75 years.

  • Klar verbesserte Versorgung von Gichtpatienten durch maßgeschneiderte Aufklärung in England

    Die persönliche Betreuung von Gichtpatienten durch „Study Nurses“ verbesserte in England die Therapietreue und senkte die Zahl der Anfälle im Vergleich zur hausärztlichen Versorgung.

  • Meta-analysis: educational, behavioral interventions improve gout outcomes

    Interventions were led by pharmacists, nurses, or PCPs.

  • Gout tied to 15% greater risk for dementia in elders

    Observational cohort of 1.71 million Medicare beneficiaries using claims data.

  • ACFAS, AANP release consensus statement on gouty arthritis

    Risk factors, diagnosis, and treatment of gouty arthritis of the foot and ankle.

  • Gout: genes more important than diet, says meta-analysis

    Individuals' predisposition to gout is less modifiable than previously thought.

  • Study challenges belief that gout is caused by diet
    Study challenges belief that gout is caused by diet

    Dietary scores explained less than 0.3 per cent of variations in serum urate levels.

  • Gout: allopurinol tied to lower risk for advanced CKD

    Link seen with doses of at least 300 mg/day, but not lower doses.

  • Meta-analysis: sugary beverages tied to gout, hyperuricemia

    Meta-analysis of 10 studies with >50,000 participants.

  • CANTOS: canakinumab cuts new gout attacks without altering SUA

    IL-1β blockade is a new treatment strategy for gout.

  • Stage III CKD: febuxostat fails to mitigate renal function decline

    Data from the randomized FEATHER trial.

  • OSA tied to increased risk for gout, independent of BMI

    Nearly 16,000 OSA cases studied in matched retrospective cohort.

  • Gout tied to higher odds of hearing loss in elderly

    Association found independent of known risk factors.

  • Gout: phase 3 data support febuxostat IR, XR in renal impairment

    Both are reasonable treatment options for gout.

  • Preexisting gout: hospitalizations increase acute arthritic flares 10-fold

    Flares were linked to longer hospital stays.

  • Daily text improves treatment adherence in patients with gout
    Daily text improves treatment adherence in patients with gout

    A randomised controlled trial demonstrates significant effect on adherence rates over 12 weeks.

  • Gout: canakinumab reduces flares by more than half
    Gout: canakinumab reduces flares by more than half

    A secondary analysis of data from the CANTOS trial, presented at EULAR 2018.

  • Mehr laden